Purchases and Sales Made in Q4 2024 in Igm Biosciences, Inc. (IGMS)
This table provides information about the institutional ownership of Igm Biosciences, Inc. (IGMS) during Q4 2024. The information is specifically focused on institutions that hold shares of IGM Biosciences, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2025
Q4 2024
|
Susquehanna Portfolio Strategies, LLC
Bala Cynwyd, PA |
SELL
|
- |
-15.8K- 52.38% |
$95.7K - $282K
|
14.4K
$19.4K
|
|
|
Feb 14, 2025
Q4 2024
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-22K- 52.35% |
$133K - $393K
|
20K
$27.1K
|
|
|
Jun 30, 2025
Q4 2024
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-35.5K- 76.0% |
$215K - $634K
|
11.2K
$15.2K
|
|
|
Feb 14, 2025
Q4 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-48.9K- 36.93% |
$296K - $871K
|
83.5K
$113K
|
|
|
Feb 13, 2025
Q4 2024
|
Rhenman & Partners Asset Management Ab
Stockholm, V7 |
SELL
|
- |
-59.4K- 32.03% |
$359K - $1.06M
|
126K
$170K
|
|
|
Feb 14, 2025
Q4 2024
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-87.6K- 89.66% |
$530K - $1.56M
|
10.1K
$13.6K
|
|
|
Feb 14, 2025
Q4 2024
|
Redmile Group, LLC
San Francisco, CA |
SELL
|
- |
-120K- 3.92% |
$728K - $2.15M
|
2.95M
$3.99M
|
|
|
Feb 11, 2025
Q4 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-281K- 22.29% |
$1.7M - $5.01M
|
978K
$1.32M
|
|
|
Feb 14, 2025
Q4 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-445K- 11.09% |
$2.69M - $7.94M
|
3.57M
$4.82M
|